P09.53 Comparative Effectiveness of Crizotinib versus Entrectinib in ROS1+ Non-Small Cell Lung Cancer (NSCLC) using Clinical Trial and Real-World Data

Authors :: Gabriel Tremblay
R. Wiltshire
L. Bartolome
Keith D. Wilner
M. Groff
L. Iadeluca
R. Camidge
Joseph C. Cappelleri
Tiziana Usari
Source :: Journal of Thoracic Oncology. 16:S314-S315
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Crizotinib
business.industry
non-small cell lung cancer (NSCLC)
Entrectinib
medicine.disease
Clinical trial
Internal medicine
medicine
ROS1
business
Real world data
medicine.drug

Tools